ANSLF (Ansell) EBIT : $130 Mil (TTM As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Ansell EBIT?

Ansell's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was $90 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was $130 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Ansell's annualized ROC % for the quarter that ended in Jun. 2024 was 3.70%. Ansell's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 21.03%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Ansell's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was 4.25%.

Ansell EBIT Historical Data

The historical data trend for Ansell's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ansell EBIT Chart

Ansell Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

EBIT

Get a 7-Day Free Trial

223.10

337.50

226.60

207.20

129.70

Ansell Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBIT	Get a 7-Day Free Trial															116.20	91.70	115.50	39.50	90.20

Competitive Comparison of Ansell's EBIT

For the Medical Instruments & Supplies subindustry, Ansell's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ansell's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ansell's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ansell's EV-to-EBIT falls into.

Ansell EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $130 Mil.

Ansell (OTCPK:ANSLF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Ansell's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

	ROC % (Q: Jun. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Jun. 2024 ))	/ count )
=	106.8 * ( 1 - 27.67% )	/	( (2119.9	+	2058.9)	/ 2 )
=	77.24844	/	2089.4
=	3.70 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	2525.2	-	240.2	-	( 165.1	-	max(0, 423.2	-	891	+	165.1	))
=	2119.9

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	3242.6	-	271.4	-	( 912.3	-	max(0, 423.4	-	1623.9	+	912.3	))
=	2058.9

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Ansell's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Jun. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	180.4	/	( ( (440.4 + max(421, 0))	+	(435.5 + max(418.8, 0)) )	/	2 )
=	180.4	/	( ( 861.4	+	854.3 )	/	2 )
=	180.4	/	857.85
=	21.03 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(198.2	+	490	+	37.7)	-	(240.2	+	5.1	+	59.6)
=	421

	Working Capital		(Q: Jun. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(265	+	457.9	+	41.8)	-	(271.4	+	9.4	+	65.1)
=	418.8

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Ansell's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2024 )
	=	129.7	/	3053.511
	=	4.25 %

Ansell EBIT Related Terms

Thank you for viewing the detailed overview of Ansell's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Ansell Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ansell Ltd (OTCPK:ANSLF) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

ANSLY:USA PD1A:Germany ANN:Australia

Address

678 Victoria Street, Level 3, Richmond, VIC, AUS, 3121

Website

https://www.ansell.com

Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 60% of revenue and 70% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2022, Ansell earned 45% of revenue in North America, 33% from Europe, Middle East and Africa, 14% across Asia-Pacific and the remaining 8% in Latin America.